|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/10 | (2006.01) |
| A61K 9/16 | (2006.01) | ||
| A61K 47/14 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 38/26 | (2006.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 14/605 | (2006.01) |
| (11) | Number of the document | 2157967 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08743213.4 |
| Date of filing the European patent application | 2008-04-22 | |
| (97) | Date of publication of the European application | 2010-03-03 |
| (45) | Date of publication and mention of the grant of the patent | 2013-01-16 |
| (46) | Date of publication of the claims translation | 2013-05-27 |
| (86) | Number | PCT/US2008/005235 |
| Date | 2008-04-22 |
| (87) | Number | WO 2008/133908 |
| Date | 2008-11-06 |
| (30) | Number | Date | Country code |
| 926005 P | 2007-04-23 | US | |
| 72202 P | 2008-03-28 | US |
| (72) |
ALESSI, Thomas, R., US
MERCER, Ryan, D., US
ROHLOFF, Catherine, M., US
YANG, Bing, US
|
| (73) |
Intarcia Therapeutics, Inc,
24650 Industrial Boulevard, Hayward CA 94545,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Insulinotropinių peptidų suspensijos vaisto formos ir jų panaudojimas |
| SUSPENSION FORMULATIONS OF INSULINOTROPIC PEPTIDES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-01 | 18 | 347.00 EUR |
| 2026-04-22 |